icon
0%

Chevron Corporation CVX - News Analyzed: 10,791 - Last Week: 100 - Last Month: 400

β‡— Chevron Corporation CVX's Market Positioning Enhanced Amidst Volatile Bio-Tech Market

Chevron Corporation CVX's Market Positioning Enhanced Amidst Volatile Bio-Tech Market
Synergy Asset Management and Kozak & Associates reduced their stakes in Chevron Corporation $CVX, while Elevatus Welath Management, Nordea Investment Management AB, RF&L Wealth Management, Ausdal Financial Partners, Focus Partners Wealth, NorthCrest Asset Manangement and Capital International Inc. CA are among firms that increased their stakes. This shows investment actions are mixed for Chevron, an institution with 67% ownership, which has important implications for the business's future. Barclays has increased its price target to $180 from $172 on the stock, citing specific undisclosed reasons. Furthermore, Argus Research has also raised the target considering favorable shareholder returns. Meanwhile, Moody National Bank Trust Division, Richard Bernstein Advisors and HITE Hedge Asset Management sold their shares. Chevron's by-laws were modified to strengthen board governance following its acquisition of Hess, which boosted its exposure in Guyana. The oil giant sees $130-$140 oil as a reality, indicating potential turmoil in the market. Chevron's performance appears to be due to more than just rising oil prices, as the stock witnesses a surge. The corporation has been given a consensus rating of 'Hold' by diversified brokerage firms. However, upgrades to 'Buy' were also noted in response to the Hess acquisition and due to improving crude environment.

Chevron Corporation CVX News Analytics from Sat, 09 Aug 2025 07:00:00 GMT to Sat, 28 Mar 2026 09:59:52 GMT - Rating 4 - Innovation 2 - Information 6 - Rumor 1

The email address you have entered is invalid.